Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Acq. announced
CC transcript
|
|
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2021 |
3
| Waltermire Robert E. (Senior VP, Chief Pharma Dev.) has filed a Form 3 on MADRIGAL PHARMACEUTICALS, INC. |
| 05/19/2021 |
3
| Howarth Alex G. (CFO) has filed a Form 3 on MADRIGAL PHARMACEUTICALS, INC. |
| 04/02/2020 |
3
| Sukhija Remy (SVP and Chief Comm'l Officer) has filed a Form 3 on MADRIGAL PHARMACEUTICALS, INC. |
| 07/01/2019 |
3
| Daly James M (Director) has filed a Form 3 on MADRIGAL PHARMACEUTICALS, INC. |
| 05/08/2019 |
3
| Lynch Brian Joseph (SVP and General Counsel) has filed a Form 3 on MADRIGAL PHARMACEUTICALS, INC. |
| 11/21/2016 |
3
| Levy Richard S (Director) has filed a Form 3 on MADRIGAL PHARMACEUTICALS, INC. |
| 07/29/2016 |
3
| BATE KENNETH (Director) has filed a Form 3 on SYNTA PHARMACEUTICALS CORP |
| 07/29/2016 |
3
| MILLIGAN DAVID V (Director) has filed a Form 3 on SYNTA PHARMACEUTICALS CORP |
| 07/26/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 07/26/2016 |
3
| CRAVES FRED B (10% Owner) has filed a Form 3 on SYNTA PHARMACEUTICALS CORP |
| 07/26/2016 |
3
| FRIEDMAN PAUL A (CEO) has filed a Form 3 on SYNTA PHARMACEUTICALS CORP |
| 07/26/2016 |
3
| Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 3 on SYNTA PHARMACEUTICALS CORP |
| 03/13/2013 |
3
| Ramachandra Sumant (President, R&D) has filed a Form 3 on SYNTA PHARMACEUTICALS CORP |
| 11/30/2010 |
3
| Singh Amar (Sr. VP, Business & Comm. Dvp.) has filed a Form 3 on SYNTA PHARMACEUTICALS CORP |
| 09/30/2010 |
3
| KUFE DONALD W (Director) has filed a Form 3 on SYNTA PHARMACEUTICALS CORP |
| 07/13/2009 |
3
| Vukovic Vojo (SVP, Chief Medical Officer) has filed a Form 3 on SYNTA PHARMACEUTICALS CORP |
|
|